Characteristics of medication errors among respiratory drugs within the Food and Drug Administration’s Adverse Event Reporting System
V. Pera (Rotterdam, Netherlands), P. Rijnbeek (Rotterdam, Netherlands), J. Van Der Lei (Rotterdam, Netherlands), J. Kors (Rotterdam, Netherlands), R. Parry (Rotterdam, Netherlands), E. Van Mulligen (Rotterdam, Netherlands), M. De Wilde (Rotterdam, Netherlands), G. Brusselle (Rotterdam, Netherlands), G. Brusselle (Ghent, Belgium), K. Verhamme (Rotterdam, Netherlands)
Source: International Congress 2022 – Miscellaneous: biomarkers for the management of chronic lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Pera (Rotterdam, Netherlands), P. Rijnbeek (Rotterdam, Netherlands), J. Van Der Lei (Rotterdam, Netherlands), J. Kors (Rotterdam, Netherlands), R. Parry (Rotterdam, Netherlands), E. Van Mulligen (Rotterdam, Netherlands), M. De Wilde (Rotterdam, Netherlands), G. Brusselle (Rotterdam, Netherlands), G. Brusselle (Ghent, Belgium), K. Verhamme (Rotterdam, Netherlands). Characteristics of medication errors among respiratory drugs within the Food and Drug Administration’s Adverse Event Reporting System. 230
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|